Cargando…

The genetic basis of major depressive disorder

The genetic dissection of major depressive disorder (MDD) ranks as one of the success stories of psychiatric genetics, with genome-wide association studies (GWAS) identifying 178 genetic risk loci and proposing more than 200 candidate genes. However, the GWAS results derive from the analysis of coho...

Descripción completa

Detalles Bibliográficos
Autor principal:	Flint, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Expert Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611584/ https://www.ncbi.nlm.nih.gov/pubmed/36702864 http://dx.doi.org/10.1038/s41380-023-01957-9

Ejemplares similares

Molecular pathways of major depressive disorder converge on the synapse
por: Fries, Gabriel R., et al.
Publicado: (2022)

Duloxetine in the treatment of major depressive disorder
por: Goldstein, David J
Publicado: (2007)

Desvenlafaxine in the treatment of major depressive disorder
por: Lourenco, Maria Teresa C, et al.
Publicado: (2009)

Transdermal selegiline for the treatment of major depressive disorder
por: Lee, Kelly C, et al.
Publicado: (2007)

Brain connectivity in major depressive disorder: a precision component of treatment modalities?
por: Tura, Asude, et al.
Publicado: (2023)

A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia
por: McGuinness, A. J., et al.
Publicado: (2022)

Augmentation treatment in major depressive disorder: focus on aripiprazole
por: Nelson, J Craig, et al.
Publicado: (2008)

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
por: Baune, Bernhard T
Publicado: (2008)

The Genetics of Major Depression
por: Flint, Jonathan, et al.
Publicado: (2014)

Ivermectin Resistance in Onchocerca volvulus: Toward a Genetic Basis
por: Lustigman, Sara, et al.
Publicado: (2007)

Molecular genetics of cocaine use disorders in humans
por: Fernàndez-Castillo, Noèlia, et al.
Publicado: (2021)

The Genetics of Major Depression
por: Flint, Jonathan, et al.
Publicado: (2014)

Initial evidence regarding the neurobiological basis of psychological symptoms in dementia caregivers
por: Smagula, Stephen F., et al.
Publicado: (2023)

What next for eating disorder genetics? Replacing myths with facts to sharpen our understanding
por: Huckins, Laura M., et al.
Publicado: (2022)

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
por: Howland, Robert H
Publicado: (2009)

A genetics-first approach to understanding autism and schizophrenia spectrum disorders: the 22q11.2 deletion syndrome
por: Fiksinski, Ania M., et al.
Publicado: (2022)

Cancer is a Preventable Disease that Requires Major Lifestyle Changes
por: Anand, Preetha, et al.
Publicado: (2008)

Epilogue: Lessons from the CONVERGE study of major depressive disorder in China
por: Flint, Jonathan, et al.
Publicado: (2012)

Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine
por: Khanra, Sourav, et al.
Publicado: (2023)

Evidence-Based Pharmacotherapy for Pediatric Obsessive-Compulsive Disorder and Chronic Tic Disorders
por: De Nadai, Alessandro S., et al.
Publicado: (2011)

Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis
por: Margoni, Monica, et al.
Publicado: (2023)

Evolution of genetic networks for human creativity
por: Zwir, I., et al.
Publicado: (2021)

Genetic variation, brain, and intelligence differences
por: Deary, Ian J., et al.
Publicado: (2021)

Glycosylation and behavioral symptoms in neurological disorders
por: Pradeep, Prajitha, et al.
Publicado: (2023)

Biological factors influencing depression in later life: role of aging processes and treatment implications
por: Szymkowicz, Sarah M., et al.
Publicado: (2023)

Genetic basis of cognitive disability
por: Flint, Jonathan
Publicado: (2001)

Genetics and intelligence differences: five special findings
por: Plomin, R, et al.
Publicado: (2015)

Social circuits and their dysfunction in autism spectrum disorder
por: Sato, Masaaki, et al.
Publicado: (2023)

Novel epigenetic molecular therapies for imprinting disorders
por: Wang, Sung Eun, et al.
Publicado: (2023)

Armodafinil in the treatment of sleep/wake disorders
por: Schwartz, Jonathan RL, et al.
Publicado: (2010)

Heroin and its metabolites: relevance to heroin use disorder
por: Milella, Michele Stanislaw, et al.
Publicado: (2023)

Mood Disorders, Circadian Rhythms, Melatonin and Melatonin Agonists
por: Quera Salva, M.A., et al.
Publicado: (2012)

The Need for Restructuring the Disordered Science of Amorphous Drug Formulations
por: Edueng, Khadijah, et al.
Publicado: (2017)

Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations
por: Augestad, Knut Magne, et al.
Publicado: (2017)

The neurobiology of apathy in depression and neurocognitive impairment in older adults: a review of epidemiological, clinical, neuropsychological and biological research
por: Steffens, David C., et al.
Publicado: (2022)

Modeling psychiatric disorders: from genomic findings to cellular phenotypes
por: Falk, A, et al.
Publicado: (2016)

Evolution of gamma knife capsulotomy for intractable obsessive-compulsive disorder
por: Miguel, Euripedes C., et al.
Publicado: (2018)

Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders
por: Rana, Sarosh, et al.
Publicado: (2022)

Mapping the genetic architecture of cortical morphology through neuroimaging: progress and perspectives
por: van der Meer, Dennis, et al.
Publicado: (2022)

Maternal brain reactive antibodies profile in autism spectrum disorder: an update
por: Bagnall-Moreau, Ciara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_59pnb0i9j3jde45u0emrnf59mq